ADRO Insider Trading Activity and SEC Form 4 Filings
ADRO insider trading summary
No open-market insider purchases or sales of Aduro Biotech, Inc. (ADRO) have been reported on SEC Form 4 in the past 12 months.
Latest ADRO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 15, 2020 | Stephen T Isaacs | President and CEO | Sell | $78K (32,481 @ $2.39) |
| Sep 15, 2020 | Celeste Ferber | SVP, GC and Secretary | Sell | $6K (2,396 @ $2.39) |
| Sep 15, 2020 | Blaine Templeman | Chief Legal Officer | Sell | $30K (12,369 @ $2.39) |
| Aug 7, 2020 | Blaine Templeman | Chief Legal Officer | Sell | $20K (7,951 @ $2.55) |
| Aug 7, 2020 | Celeste Ferber | SVP, GC and Secretary | Sell | $20K (7,951 @ $2.55) |
| Aug 7, 2020 | Dimitry SA Nuyten | Chief Medical Officer | Sell | $9K (3,538 @ $2.55) |
| Feb 25, 2020 | Elsas Andrea van | Chief Scientific Officer | Sell | $24K (6,823 @ $3.51) |
| Jan 3, 2020 | Elsas Andrea van | Chief Scientific Officer | Sell | $87K (73,311 @ $1.19) |
| Dec 12, 2019 | Blaine Templeman | Chief Legal Officer | Sell | $1K (1,264 @ $1.16) |
| Dec 12, 2019 | Elsas Andrea van | Chief Scientific Officer | Sell | $3K (2,192 @ $1.16) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.